Skip to content

Side by side

Tesamorelin vs Thymalin

Both are discussed for anti-aging & longevity. What this site records about each, side by side. Every figure is on the compound's own page with the source it came from.

Tesamorelin and Thymalin compared on what BioAlmanac records.
 TesamorelinThymalin
What it isA GHRH analogue approved by the FDA for reducing excess visceral fat in HIV-associated lipodystrophy. The only compound in this category with completed phase 3 trials.A thymus extract used as a medicine in Russia for decades. Not a single defined peptide, which is the fact that governs everything else on this page.
EvidenceHow much human evidence exists, not how well it works.Approved for another indicationEarly human trials
Regulatory statusReviewed 2026-08-12Approved by the FDA as a prescription medicine for reducing excess visceral abdominal fat in adults with HIV-associated lipodystrophy. It is not approved for body composition, athletic performance or anti-ageing use, and material sold as a research chemical is not the approved product.Registered as a medicine in Russia and several neighbouring states for immune-related indications. Not approved in the United States, the European Union or the United Kingdom, where it is sold only as a research chemical. Because it is an extract rather than a synthesised peptide, purity and composition vary between producers in a way they do not for defined peptides.
RoutesSubcutaneousIntramuscular, Subcutaneous
Half-life0.4 hoursNot recorded
Cheapest per mgVials only, read from vendors' own listings and dated on the price index.$2.35/mg$1.30/mg
Median per mg$7.00/mg$4.50/mg
Vendors with a price4913
Storage once mixedRefrigerated at 2–8 °C. The approved product is intended for use shortly after reconstitution rather than stored for weeks.Refrigerated at 2–8 °C, and used within days rather than weeks. Biological extracts are less predictable in solution than synthetic peptides.

Compare two other compounds · The full price index

This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on BioAlmanac is medical advice. Nothing here ranks these two against each other. A table can show that one has more human evidence behind it or costs less per milligram; neither of those is a recommendation, and the right comparison for any person is one their doctor makes with them.